Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial
Neuropsychopharmacology (New York, N.Y.), 2017-08, Vol.42 (9), p.1776-1788 [Peer Reviewed Journal]Copyright Nature Publishing Group Aug 2017 ;Copyright © 2017 American College of Neuropsychopharmacology 2017 American College of Neuropsychopharmacology ;ISSN: 0893-133X ;EISSN: 1740-634X ;DOI: 10.1038/npp.2017.10 ;PMID: 28091532
Full text available